These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11417988)

  • 1. (131)I-MIBG radionuclide therapy is safe and cost-effective in the control of symptoms of the carcinoid syndrome.
    Pathirana AA; Vinjamuri S; Byrne C; Ghaneh P; Vora J; Poston GJ
    Eur J Surg Oncol; 2001 Jun; 27(4):404-8. PubMed ID: 11417988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [131I]MIBG radionuclide therapy in carcinoid syndrome.
    Taal BG; Zuetenhorst H; Valdés Olmos RA; Hoefnagel CA
    Eur J Surg Oncol; 2002 Apr; 28(3):243. PubMed ID: 11944956
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG): pharmacological MIBG, 131I-labelled MIBG and the combination.
    Zuetenhorst H; Taal BG; Boot H; Valdes Olmos R; Hoefnagel C
    Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1157-64. PubMed ID: 10524647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors.
    Taal BG; Hoefnagel CA; Valdes Olmos RA; Boot H; Beijnen JH
    J Clin Oncol; 1996 Jun; 14(6):1829-38. PubMed ID: 8656251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved effect of 131I-MIBG treatment by predosing with non-radiolabeled MIBG in carcinoid patients, and studies in xenografted mice.
    Taal BG; Hoefnagel C; Boot H; Valdés Olmos R; Rutgers M
    Ann Oncol; 2000 Nov; 11(11):1437-43. PubMed ID: 11142484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and medullary carcinoma of the thyroid with (131)I-meta-iodobenzylguanidine [(131)I-mIBG].
    Mukherjee JJ; Kaltsas GA; Islam N; Plowman PN; Foley R; Hikmat J; Britton KE; Jenkins PJ; Chew SL; Monson JP; Besser GM; Grossman AB
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):47-60. PubMed ID: 11453952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
    Bomanji J; Mather S; Moyes J; Ellison D; Grossman A; Britton KE; Besser GM
    J Nucl Med; 1992 Jun; 33(6):1121-4. PubMed ID: 1597726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ¹¹¹In-DTPA⁰-octreotide (Octreoscan), ¹³¹I-MIBG and other agents for radionuclide therapy of NETs.
    Bomanji JB; Papathanasiou ND
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S113-25. PubMed ID: 22388626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine-131-MIBG therapy of a patient with carcinoid liver metastases.
    Prvulovich EM; Stein RC; Bomanji JB; Ledermann JA; Taylor I; Ell PJ
    J Nucl Med; 1998 Oct; 39(10):1743-5. PubMed ID: 9776280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The palliative role of 131I-MIBG and 111In-octreotide therapy in patients with metastatic progressive neuroendocrine neoplasms.
    Pasieka JL; McEwan AJ; Rorstad O
    Surgery; 2004 Dec; 136(6):1218-26. PubMed ID: 15657579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome and toxicity after dose-intensified treatment with 131I-MIBG for advanced metastatic carcinoid tumors.
    Ezziddin S; Sabet A; Logvinski T; Alkawaldeh K; Yong-Hing CJ; Ahmadzadehfar H; Grünwald F; Biersack HJ
    J Nucl Med; 2013 Dec; 54(12):2032-8. PubMed ID: 24101685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.
    Macfarlane D; Gonin J; Wieland D; Mangner T; Froelich J; Beierwaltes W; Shapiro B
    Eur J Nucl Med; 1996 Feb; 23(2):131-40. PubMed ID: 8925846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide scanning for carcinoid tumours.
    Critchley M
    Postgrad Med J; 1997 Jul; 73(861):399-402. PubMed ID: 9338023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours.
    Nocaudie-Calzada M; Huglo D; Carnaille B; Proye C; Marchandise X
    Eur J Nucl Med; 1996 Nov; 23(11):1448-54. PubMed ID: 8854840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 131I-meta-iodobenzylguanidine in the management of metastatic midgut carcinoid tumors.
    Sywak MS; Pasieka JL; McEwan A; Kline G; Rorstad O
    World J Surg; 2004 Nov; 28(11):1157-62. PubMed ID: 15490060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [111IN-octreotide and 123I-MIBG scintigraphy in the diagnosis of small intestinal carcinoid tumors--results of a comparative investigation].
    Dresel S; Tatsch K; Zachoval R; Hahn K
    Nuklearmedizin; 1996 Apr; 35(2):53-8. PubMed ID: 8721576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients.
    Safford SD; Coleman RE; Gockerman JP; Moore J; Feldman J; Onaitis MW; Tyler DS; Olson JA
    Cancer; 2004 Nov; 101(9):1987-93. PubMed ID: 15455358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific binding and uptake of 131I-MIBG and 111In-octreotide in metastatic paraganglioma--tools for choice of radionuclide therapy.
    Spetz J; Dalmo J; Nilsson O; Wängberg B; Ahlman H; Forssell-Aronsson E
    Horm Metab Res; 2012 May; 44(5):400-4. PubMed ID: 22566195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced tumor uptake in neuroendocrine tumors after intraarterial application of 131I-MIBG.
    Brogsitter C; Pinkert J; Bredow J; Kittner T; Kotzerke J
    J Nucl Med; 2005 Dec; 46(12):2112-6. PubMed ID: 16330578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality palliative treatment of (111)In-pentetreotide negative/(123)I-MIBG positive metastatic carcinoid - a case report.
    Dworakowska D; Gueorguiev M; Laji K; Grossman AB
    Endokrynol Pol; 2008; 59(4):342-7. PubMed ID: 18777505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.